VitaDAO, a decentralized autonomous organization (DAO) collective dedicated to early-stage longevity research, funded the launch of a biotech company, Matrix Biosciences, which is dedicated to treating cancer and aging diseases.
The initial discussions around the use of high molecular weight hyaluronic acid (HMW-HA) for anti-cancer and pro-longevity effects started in November 2022 and gained majority consensus in March 2023. The proposal snapshot reveals that 35 members cast their votes using VITA tokens.